Letrohope 2.5 Mg (5 Tab)

Letrohope 2.5 MG (5 TAB)

Letrohope 2.5 mg is a medication manufactured by Mankind Pharma Ltd. containing Letrozole as its active ingredient.

• Name:

  • Common Name: Letrozole
  • Brand Name: Letrohope 2.5 Tablet

• Composition:

  • Each tablet contains 2.5 mg of Letrozole.

• Uses: Letrohope 2.5 mg is primarily used in postmenopausal women for:

  • Breast Cancer Treatment: It is prescribed for hormone-receptor-positive breast cancer, including early-stage, advanced, or metastatic disease. It can be used as initial therapy, adjuvant therapy (after surgery to reduce recurrence), or neoadjuvant therapy (to shrink tumors before surgery).
  • Infertility due to Anovulation: It is also used to induce ovulation in women experiencing infertility caused by anovulation.

• Dosage and Administration:

  • The typical dosage is 2.5 mg orally once daily, or as directed by a healthcare professional.
  • It can be taken with or without food, preferably at the same time each day.
  • Tablets should be swallowed whole with a glass of water and not crushed, chewed, or broken.
  • The duration of treatment is determined by the doctor based on the patient's condition and response.

• Side Effects:

  • Common Side Effects: Hot flushes (sudden feeling of warmth), increased sweating, fatigue, weakness, joint pain, bone pain, headache, dizziness, nausea, vomiting, diarrhea, indigestion, constipation, skin rashes, increased or decreased appetite, vaginal dryness, vaginal bleeding, hypercholesterolemia (high cholesterol levels), and edema (swelling).
  • Serious Side Effects (rare): These may include stroke, angina, heart attack, blood clotting, cataract, osteoporosis, and severe skin reactions. Letrohope 2.5 mg can also cause thinning or wasting of bones (osteoporosis) due to decreased estrogen levels.

• Precautions:

  • Letrohope 2.5 mg is contraindicated in premenopausal women, pregnant or breastfeeding women, and individuals allergic to Letrozole or any other ingredients.
  • Caution is advised in patients with liver disease; dose adjustment may be necessary in cases of severe hepatic dysfunction.
  • It may cause dizziness and drowsiness, so caution should be exercised when driving or operating machinery.
  • Bone mineral density monitoring is recommended before, during, and after treatment due to the risk of osteoporosis.
  • Patients should inform their doctor if they experience tendon pain or swelling.
  • Alcohol consumption should be avoided as it may increase drowsiness and dizziness.
  • Letrohope 2.5 mg may interact with other medications, including tamoxifen, estrogen-containing products, other aromatase inhibitors, and certain liver enzyme-modifying drugs.
  • Not recommended for use in children or adolescents.
  • Cholesterol levels should be monitored regularly.

• Storage:

  • Store Letrohope 2.5 mg tablets in a cool and dry place, protected from direct sunlight, moisture, and heat.
  • Keep out of reach of children.
  • Store at room temperature (between 20°C and 25°C, or below 30°C).

Letrohope 2.5 mg contains Letrozole, an anti-cancer medication used primarily in postmenopausal women. It is also sometimes used off-label for fertility treatments.

What is Letrohope 2.5 mg used for?

Letrohope 2.5 mg is predominantly used to treat certain types of breast cancer in women who have gone through menopause. This includes early-stage breast cancer, locally advanced breast cancer, and metastatic breast cancer that has spread to other parts of the body. It can be used as adjuvant therapy after surgery to reduce the risk of recurrence, or as neoadjuvant therapy to shrink tumors before surgery. Additionally, Letrozole, the active ingredient, is sometimes used off-label for ovulation induction in female infertility, particularly in cases of polycystic ovary syndrome (PCOS).

How does Letrohope 2.5 mg work?

Letrohope 2.5 mg contains Letrozole, which is a non-steroidal aromatase inhibitor. It works by blocking the enzyme aromatase, which is responsible for converting other sex hormones (androgens) into estrogen in the body, especially in postmenopausal women. Since some breast cancers are estrogen-dependent, reducing estrogen levels slows or stops the growth and spread of these cancer cells.

What is the usual dosage?

The recommended dosage for Letrohope 2.5 mg for breast cancer is one 2.5 mg tablet taken once daily. It should ideally be taken at the same time each day, with or without food. For fertility treatment, the usual dose is 2.5 mg to 5 mg daily for 5 days, typically starting on day 3-5 of the menstrual cycle.

What are the possible side effects?

Common side effects of Letrohope 2.5 mg include hot flashes, joint pain, bone pain, fatigue, increased sweating, headache, dizziness, nausea, vomiting, and hair loss. More serious, though less common, side effects can include osteoporosis (bone thinning), bone fractures, high cholesterol, high blood pressure, and cardiovascular issues. Rarely, severe reactions like blood clots, stroke, heart attack, or severe skin reactions may occur.

Is it safe during pregnancy or breastfeeding?

Letrohope 2.5 mg is not safe during pregnancy and is contraindicated for pregnant women as it may harm the unborn baby. Women who still have the potential to become pregnant should use effective birth control during treatment and for at least 3 weeks after the last dose. It is also not recommended during breastfeeding, and breastfeeding should be avoided for at least 3 weeks after the last dose, as it is not known if Letrozole passes into breast milk and could harm the baby.

Can it be taken with other medications?

Letrohope 2.5 mg can interact with other medications. Concomitant use with tamoxifen (another breast cancer drug) should be avoided as it can alter the effects of Letrozole. Other medicines like warfarin (a blood thinner), cimetidine (for stomach ulcers), phenytoin, and clopidogrel should be used with caution. Certain dietary supplements like androstenedione or DHEA, and estrogen-containing medications (e.g., estradiol) can also interact with Letrozole. It's crucial to inform your doctor about all medications, over-the-counter drugs, and herbal supplements you are taking.

What precautions should be taken?

Inform your doctor if you have any liver or kidney diseases, bone problems (like osteoporosis), or high cholesterol, as Letrohope 2.5 mg may worsen these conditions or require dose adjustments. Letrozole can cause dizziness, drowsiness, or fatigue, so caution should be exercised when driving or operating machinery until you know how the medicine affects you. Routine monitoring of bone mineral density and lipid profiles (cholesterol and fats) may be recommended during treatment.

What happens if a dose is missed?

If you miss a dose of Letrohope 2.5 mg, take it as soon as you remember. However, if it is almost time for your next scheduled dose (e.g., less than 3 hours according to some guidelines, or over 12 hours according to others), skip the missed dose and continue with your regular dosing schedule. Do not take a double or extra dose to make up for the forgotten one.

How should it be stored?

Letrohope 2.5 mg tablets should be stored in a cool and dry place, protected from direct sunlight, moisture, and heat. Keep the medication out of the reach of children and pets. Do not use expired or damaged medicines and dispose of any unused medicine properly, as advised by your pharmacist or healthcare provider.